BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31521106)

  • 1. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer.
    Liu Q; Guo L; Zhang S; Wang J; Lin X; Gao F
    Mol Med; 2019 Sep; 25(1):44. PubMed ID: 31521106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Thai family with hereditary pancreatitis and increased cancer risk due to a mutation in PRSS1 gene.
    Pho-Iam T; Thongnoppakhun W; Yenchitsomanus PT; Limwongse C
    World J Gastroenterol; 2005 Mar; 11(11):1634-8. PubMed ID: 15786540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRSS1 intron mutations in patients with pancreatic cancer and chronic pancreatitis.
    Gao F; Liu QC; Zhang S; Zhuang ZH; Lin CZ; Lin XH
    Mol Med Rep; 2012 Feb; 5(2):449-51. PubMed ID: 22109105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations of PRSS1 gene in patients with pancreatic cancer among Han population.
    Zeng K; Liu QC; Lin JH; Lin XH; Zhuang ZH; Gao F; Ou QS
    Chin Med J (Engl); 2011 Jul; 124(13):2065-7. PubMed ID: 22088471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.
    Schubert S; Traub F; Brakensiek K; von Kopylow K; Marohn B; Maelzer M; Gaedcke J; Kreipe H; Stuhrmann M
    Pancreas; 2014 Oct; 43(7):1078-82. PubMed ID: 25003218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer.
    Yi Q; Dong F; Lin L; Liu Q; Chen S; Gao F; He Q
    Tumour Biol; 2016 May; 37(5):5805-10. PubMed ID: 26546433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis.
    Chang MC; Jan IS; Liang PC; Jeng YM; Yang CY; Tien YW; Wong JM; Chang YT
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2038-42. PubMed ID: 24909264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
    Chandak GR; Idris MM; Reddy DN; Mani KR; Bhaskar S; Rao GV; Singh L
    Gut; 2004 May; 53(5):723-8. PubMed ID: 15082592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel frame-shift mutation in PRSS1 gene in Han patients with autoimmune pancreatitis.
    Gao F; Li Y; Wang C; Zhuang Z; Liu QC; Chen J; Hong G; Xu Z
    Curr Mol Med; 2014 Mar; 14(3):340-8. PubMed ID: 24236450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.
    Grocock CJ; Rebours V; Delhaye MN; Andrén-Sandberg A; Weiss FU; Mountford R; Harcus MJ; Niemczyck E; Vitone LJ; Dodd S; Jørgensen MT; Ammann RW; Schaffalitzky de Muckadell O; Butler JV; Burgess P; Kerr B; Charnley R; Sutton R; Raraty MG; Devière J; Whitcomb DC; Neoptolemos JP; Lévy P; Lerch MM; Greenhalf W;
    Gut; 2010 Mar; 59(3):357-63. PubMed ID: 19951905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1).
    Le Maréchal C; Bretagne JF; Raguénès O; Quéré I; Chen JM; Ferec C
    Mol Genet Metab; 2001 Nov; 74(3):342-4. PubMed ID: 11708864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary chronic pancreatitis.
    Rosendahl J; Bödeker H; Mössner J; Teich N
    Orphanet J Rare Dis; 2007 Jan; 2():1. PubMed ID: 17204147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer.
    Shelton CA; Umapathy C; Stello K; Yadav D; Whitcomb DC
    Am J Gastroenterol; 2018 Sep; 113(9):1376. PubMed ID: 30018304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen.
    Archer H; Jura N; Keller J; Jacobson M; Bar-Sagi D
    Gastroenterology; 2006 Dec; 131(6):1844-55. PubMed ID: 17087933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer.
    Hengstler JG; Bauer A; Wolf HK; Bulitta CJ; Tanner B; Oesch F; Gebhard S; Boettger T
    Anticancer Res; 2000; 20(5A):2967-74. PubMed ID: 11062709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.
    Balázs A; Hegyi P; Sahin-Tóth M
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G477-86. PubMed ID: 26822915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary aspects of pancreatitis].
    Bak D; Sobczyńska-Tomaszewska A; Bal J
    Med Wieku Rozwoj; 2003; 7(1):57-66. PubMed ID: 13130170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary pancreatitis as the premalignant disease: a Japanese case of pancreatic cancer involving the SPINK1 gene mutation N34S.
    Masamune A; Mizutamari H; Kume K; Asakura T; Satoh K; Shimosegawa T
    Pancreas; 2004 Apr; 28(3):305-10. PubMed ID: 15084977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.